Two‐step evolution of the hepatitis B drug‐resistant mutations in a patient who developed primary entecavir resistance

Aim Few cases of primary entecavir resistance in chronic hepatitis B patients have been reported to date. The serial profiling of the HBV polymerase gene mutations from a treatment‐naive patient who developed drug resistance after 32 months of entecavir therapy is presented here. Design Serum sample...

Ausführliche Beschreibung